29.02
+2.19(+8.16%)
Currency In USD
| Previous Close | 26.83 |
| Open | 26.81 |
| Day High | 30.4 |
| Day Low | 26.27 |
| 52-Week High | 30.82 |
| 52-Week Low | 7.78 |
| Volume | 682,142 |
| Average Volume | 334,175 |
| Market Cap | 401.74M |
| PE | -19.88 |
| EPS | -1.46 |
| Moving Average 50 Days | 12.43 |
| Moving Average 200 Days | 10.88 |
| Change | 2.19 |
If you invested $1000 in Greenwich LifeSciences, Inc. (GLSI) since IPO date, it would be worth $5,804 as of January 14, 2026 at a share price of $29.02. Whereas If you bought $1000 worth of Greenwich LifeSciences, Inc. (GLSI) shares 5 years ago, it would be worth $808.36 as of January 14, 2026 at a share price of $29.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026
GlobeNewswire Inc.
Dec 29, 2025 11:00 AM GMT
STAFFORD, Texas, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designat
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
GlobeNewswire Inc.
Dec 22, 2025 11:00 AM GMT
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designat
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01
GlobeNewswire Inc.
Dec 15, 2025 11:00 AM GMT
STAFFORD, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immuno